Literature DB >> 15721052

A median voter model of health insurance with ex post moral hazard.

Johanna Jacob1, Douglas Lundin.   

Abstract

One of the main features of health insurance is moral hazard, as defined by Pauly [Pauly, M.V., 1968. The economics of moral hazard: comment. American Economic Review 58, 531-537), people face incentives for excess utilization of medical care since they do not pay the full marginal cost for provision. To mitigate the moral hazard problem, a coinsurance can be included in the insurance contract. But health insurance is often publicly provided. Having a uniform coinsurance rate determined in a political process is quite different from having different rates varying in accordance with one's preferences, as is possible with private insurance. We construct a political economy model in order to characterize the political equilibrium and answer questions like: "Under what conditions is there a conflict in society on what coinsurance rate should be set?" and "Which groups of individuals will vote for a higher and lower than equilibrium coinsurance rate, respectively?". We also extend our basic model and allow people to supplement the coverage provided by the government with private insurance. Then, we answer two questions: "Who will buy the additional coverage?" and "How do the coinsurance rates people are now faced with compare with the rates chosen with pure private provision?".

Entities:  

Mesh:

Year:  2004        PMID: 15721052     DOI: 10.1016/j.jhealeco.2004.01.004

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  2 in total

1.  Voluntary private health insurance among the over 50s in Europe.

Authors:  Omar Paccagnella; Vincenzo Rebba; Guglielmo Weber
Journal:  Health Econ       Date:  2012-02-07       Impact factor: 3.046

2.  Individual results may vary: Inequality-probability bounds for some health-outcome treatment effects.

Authors:  John Mullahy
Journal:  J Health Econ       Date:  2018-07-04       Impact factor: 3.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.